Viking shares surge after fatty liver drug trial
Viking Therapeutics Inc's shares more than doubled in value on Tuesday after promising data from a mid-stage trial of its fatty liver drug were seen as topping that from larger rival Madrigal Pharmaceuticals .
from Reuters: Health News https://reut.rs/2D4rv8t
http://bit.ly/2zwRqiM